Dr. Robert D Bona MD
Hematologist-Oncologist | Hematology & Oncology
263 Farmington Ave Farmington CT, 06030About
Dr. Robert Bona is a hematologist oncologist practicing in Farmington, CT. Dr. Bona specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Suny-Hlth Sci Ctr At Syracuse, Coll of Med, Syracuse Ny 1980
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
- Thrombotic complications of central venous catheters in cancer patients.
- Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation.
- Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance.
- Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
- Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
- Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis.
- Regional thrombolysis with urokinase for central venous catheter-related
- A novel combination of paclitaxel, etoposide, and cyclophosphamide for stem cell mobilization and tumor cytoreduction in ovarian cancer.
- Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
- A pilot study of busulfan, cyclophosphamide and etoposide followed by autologous transplantation for acute myeloid leukemia in remission.
- Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation.
- Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.
- Cytoreduction and stem cell mobilization with a regimen of paclitaxel, etoposide and cyclophosphamide followed by autologous transplantation using a preparative regimen of busulfan, etoposide and cyclophosphamide for patients with advanced lymphoma.
- Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation.
Dr. Robert D Bona MD's Practice location
Dr. Robert D Bona MD's reviews
Write ReviewPatient Experience with Dr. Bona
Recommended Articles
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
- Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery
It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
Nearby Providers
- Dr. Jane M Kanowitz MD41 BREWSTER RD BRISTOL CT 06010
- Dr. Adam M Boruchov MD114 WOODLAND ST HARTFORD CT 06105
- Dr. Mansour S Isckarus M.D.300 Kensington Ave New Britain CT 06051
- Dr. Susan Rabinowe MD94 Woodland St Hartford CT 06105
- Dr. Susanna Hong M.D.536 Saybrook Rd Middletown CT 06457
- Dr. Syed Bilgrami MD94 Woodland St Hartford CT 06105